The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation -

The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation
Information type: Other primary research
Source: European Heart Journal
Specialities: Cardiovascular system disorders | Haematological disorders
Summary
In this report of a validation of a new risk-scoring tool to assess bleeding risk in patients with AF, it is claimed that the five-element ORBIT bleeding risk score had better ability to predict major bleeding than either HAS-BLED and ATRIA risk scoring tools.
UKMi comment
In the NICE management of atrial fibrillation guidance (Clinical Guideline 180), it is recommended that patients being considered for, or taking, anticoagulants should have their risk of bleeding assessed using the HAS-BLED Score. ORBIT is based on an assessment of age [75+ years], reduced haemoglobin/ haematocrit/ history of anaemia, bleeding history, insufficient kidney function, and treatment with antiplatelet and is thus simpler to administer than HAS-BLED which also includes assessment of hypertension, liver disease, stroke, INR history, and alcohol use.
Related links: Editorial NICE Clinical Guideline